All the news Showing 10 of 690 articles from: Treatment issuesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Tackling hepatitis C: a tale of two countries The Lancet / 11 April 2011 New hepatitis C drugs pose many questions Keith Alcorn / 08 April 2011 Even before new hepatitis C drugs come to market later this year, the vast array of hepatitis C antivirals currently in clinical trials is opening up new horizons for treatment of hepatitis ... Pegylated Interferon Lambda Boosts Response with Few Side Effects HIVandhepatitis.com / 05 April 2011 Telaprevir Improves HCV Cure Rates Regardless of IL28B Status HIVandhepatitis.com / 05 April 2011 Polymerase Inhibitor PSI-7977 Works with Interferon or Companion Drug HIVandhepatitis.com / 05 April 2011 First Sustained Response Data for Polymerase Inhibitor Mericitabine HIVandhepatitis.com / 05 April 2011 Avalanche of hepatitis C products on the way Pharma Times / 04 April 2011 Bristol-Myers Interferon-Free Combo Cured Hepatitis Patients Bloomberg / 04 April 2011 Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France Bloomberg / 04 April 2011 Idera Pharmaceuticals Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011 Business Wire / 04 April 2011 ← Prev1...6465666768...69Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds